Skip to main content

Table 1 The treatment protocols based on the stage of disease

From: Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary

Treatment

Number of patients

Stage I.

Stage II.

Stage III.

Stage IV.

All

ABVD/EBVD + RT

3

52

9

8

72 (51.5%)

ABVD/EBVD – RT

0

5

9

9

23 (16.5%)

COPP/ABVD + RT

1

3

12

0

16 (11%)

COPP/ABVD – RT

0

0

5

2

7 (5%)

CVPP + RT

1

6

4

1

12 (9%)

CVPP – RT

1

0

2

0

3 (2%)

Other

1

2

4

0

7 (5%)

  1. A(E)BVD: adriamycin (epirubicin), bleomycin, vinblastine and dacarbazine; CV(O)PP: cyclophosphamide, vinblastine [vincristine], procarbazine and prednisolone; COPP/ABV: cyclophosphamide, vincristine, procarbazine, prednisolone/adriamycin, bleomycin and vinblastine; Other protocols include MOPP: mustargen, vincristine, procarbazin, prednisolone, OEPA: vincristine, etoposide, prednisone, and doxorubicin